DK0741708T3 - Cyanoguanidiner som K-kanal-blokkere - Google Patents
Cyanoguanidiner som K-kanal-blokkereInfo
- Publication number
- DK0741708T3 DK0741708T3 DK95907285T DK95907285T DK0741708T3 DK 0741708 T3 DK0741708 T3 DK 0741708T3 DK 95907285 T DK95907285 T DK 95907285T DK 95907285 T DK95907285 T DK 95907285T DK 0741708 T3 DK0741708 T3 DK 0741708T3
- Authority
- DK
- Denmark
- Prior art keywords
- pct
- hydrogen
- channel blockers
- c3alkyl
- sec
- Prior art date
Links
- QGBSISYHAICWAH-UHFFFAOYSA-N dicyandiamide Chemical class NC(N)=NC#N QGBSISYHAICWAH-UHFFFAOYSA-N 0.000 title 1
- 229910052739 hydrogen Inorganic materials 0.000 abstract 4
- 239000001257 hydrogen Substances 0.000 abstract 4
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 4
- 150000001875 compounds Chemical class 0.000 abstract 2
- 125000004178 (C1-C4) alkyl group Chemical group 0.000 abstract 1
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 abstract 1
- 125000000882 C2-C6 alkenyl group Chemical group 0.000 abstract 1
- 125000003601 C2-C6 alkynyl group Chemical group 0.000 abstract 1
- 206010007559 Cardiac failure congestive Diseases 0.000 abstract 1
- 208000024172 Cardiovascular disease Diseases 0.000 abstract 1
- 206010019280 Heart failures Diseases 0.000 abstract 1
- 206010020772 Hypertension Diseases 0.000 abstract 1
- 239000002253 acid Substances 0.000 abstract 1
- 125000000217 alkyl group Chemical group 0.000 abstract 1
- 239000002934 diuretic Substances 0.000 abstract 1
- 230000001882 diuretic effect Effects 0.000 abstract 1
- 125000004029 hydroxymethyl group Chemical group [H]OC([H])([H])* 0.000 abstract 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 abstract 1
- 239000003450 potassium channel blocker Substances 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/72—Nitrogen atoms
- C07D213/75—Amino or imino radicals, acylated by carboxylic or carbonic acids, or by sulfur or nitrogen analogues thereof, e.g. carbamates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Urology & Nephrology (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pyridine Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US18896994A | 1994-01-28 | 1994-01-28 | |
| PCT/US1995/000024 WO1995020579A1 (en) | 1994-01-28 | 1995-01-09 | Cyanoguanidines as k-channel blockers |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK0741708T3 true DK0741708T3 (da) | 1999-01-18 |
Family
ID=22695331
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK95907285T DK0741708T3 (da) | 1994-01-28 | 1995-01-09 | Cyanoguanidiner som K-kanal-blokkere |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US5668157A (da) |
| EP (1) | EP0741708B1 (da) |
| JP (1) | JPH09508382A (da) |
| AT (1) | ATE166343T1 (da) |
| AU (1) | AU1556695A (da) |
| CA (1) | CA2179036A1 (da) |
| DE (1) | DE69502584T2 (da) |
| DK (1) | DK0741708T3 (da) |
| ES (1) | ES2116726T3 (da) |
| MX (1) | MX9603051A (da) |
| WO (1) | WO1995020579A1 (da) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9711126D0 (en) * | 1997-05-29 | 1997-07-23 | Leo Pharm Prod Ltd | Cyanoamidines |
| GB9711124D0 (en) * | 1997-05-29 | 1997-07-23 | Leo Pharm Prod Ltd | Novel cyanoguanidines |
| GB9711123D0 (en) * | 1997-05-29 | 1997-07-23 | Leo Pharm Prod Ltd | Novel cyanoguanidines |
| GB9711127D0 (en) * | 1997-05-29 | 1997-07-23 | Leo Pharm Prod Ltd | Novel cyanoguanidines |
| GB9711125D0 (en) * | 1997-05-29 | 1997-07-23 | Leo Pharm Prod Ltd | Novel cyanoguanidines |
| WO2000061561A1 (en) | 1999-04-09 | 2000-10-19 | Shionogi Bioresearch Corp. | Cyanoguanidine compounds |
| AU5542101A (en) | 2000-04-14 | 2001-10-30 | Univ Vanderbilt | Purified and isolated potassium-chloride cotransporter nucleic acids and polypeptides and therapeutic and screening methods using same |
| WO2002062761A1 (en) * | 2001-02-07 | 2002-08-15 | Abbott Laboratories | Aminal diones as potassium channel openers |
| WO2007022964A2 (de) * | 2005-08-24 | 2007-03-01 | Abbott Gmbh & Co. Kg | Hetaryl substituierte guanidinverbindungen und ihre verwendung als bindungspartner für 5-ht5-rezeptoren |
| JP2022547083A (ja) * | 2019-09-03 | 2022-11-10 | ザルツマン グループ リミテッド | グアニジンを含むａｔｐ調節性カリウムチャネル開口薬及びその使用 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2361052C2 (de) * | 1973-12-07 | 1982-12-30 | Ruhrchemie Ag, 4200 Oberhausen | Verfahren zur Polymerisation von α-Olefinen mit 2 bis 6 Kohlenstoffatomen |
| GB1489879A (en) * | 1974-12-20 | 1977-10-26 | Leo Pharm Prod Ltd | N'-cyano-n'-3-pyridylguanidines |
| US5006523A (en) * | 1989-10-26 | 1991-04-09 | E. R. Squibb & Sons, Inc. | Antiarrhythmic agents: aryl cyanoguanidine potassium channel blockers |
| JPH03166119A (ja) * | 1989-11-24 | 1991-07-18 | Showa Alum Corp | パイプの転送装置 |
| JPH05294935A (ja) * | 1991-03-15 | 1993-11-09 | Green Cross Corp:The | アミノピリジン系化合物 |
| AU4530693A (en) * | 1992-08-13 | 1994-03-15 | Upjohn Company, The | Cyanoguanidines as potassium channel blockers |
| US5401758A (en) * | 1993-10-07 | 1995-03-28 | Bristol-Myers Squibb Company | Pyridinyl cyanoguanidine compounds |
-
1995
- 1995-01-09 DK DK95907285T patent/DK0741708T3/da active
- 1995-01-09 EP EP95907285A patent/EP0741708B1/en not_active Expired - Lifetime
- 1995-01-09 DE DE69502584T patent/DE69502584T2/de not_active Expired - Fee Related
- 1995-01-09 WO PCT/US1995/000024 patent/WO1995020579A1/en not_active Ceased
- 1995-01-09 AU AU15566/95A patent/AU1556695A/en not_active Abandoned
- 1995-01-09 JP JP7520050A patent/JPH09508382A/ja not_active Withdrawn
- 1995-01-09 ES ES95907285T patent/ES2116726T3/es not_active Expired - Lifetime
- 1995-01-09 CA CA002179036A patent/CA2179036A1/en not_active Abandoned
- 1995-01-09 MX MX9603051A patent/MX9603051A/es unknown
- 1995-01-09 AT AT95907285T patent/ATE166343T1/de not_active IP Right Cessation
- 1995-01-09 US US08/666,502 patent/US5668157A/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| AU1556695A (en) | 1995-08-15 |
| US5668157A (en) | 1997-09-16 |
| DE69502584T2 (de) | 1998-11-26 |
| MX9603051A (es) | 1997-06-28 |
| CA2179036A1 (en) | 1995-08-03 |
| ES2116726T3 (es) | 1998-07-16 |
| EP0741708A1 (en) | 1996-11-13 |
| ATE166343T1 (de) | 1998-06-15 |
| WO1995020579A1 (en) | 1995-08-03 |
| DE69502584D1 (de) | 1998-06-25 |
| EP0741708B1 (en) | 1998-05-20 |
| JPH09508382A (ja) | 1997-08-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MY135841A (en) | Novel benzodioxoles | |
| MY136926A (en) | Glucokinase activators | |
| AU1556695A (en) | Cyanoguanidines as k-channel blockers | |
| DK0654041T3 (da) | Peptidyl-4-amino-2,2-difluor-3-oxo-1,6-hexandisyre-derivater som anto-inflammatoriske midler | |
| DK0752854T3 (da) | Pyrimidin- eller triazincarboxylsyrederivater til anvendelse som lægemiddel | |
| MY110826A (en) | Cyanoguanidines as k-channel blockers | |
| DE69408580D1 (de) | 2-amino-1,2,3,4-tetrahydronaphthalenderivate mit cardiovaskulärer wirkung | |
| DK0711291T3 (da) | N-(Piperidinyl-1-alkyl)-substituerede cyclohexancarboxylsyreamider som 5-HT1A-receptorantagonister | |
| NO970474D0 (no) | N-substituerte azabicykloheptan-derivater egnet som neuroleptika | |
| FI943799A0 (fi) | Fenoksifenyylisyklopentenyylihydroksiureoita | |
| PH31388A (en) | N-benzoylmethyl-piperidines. | |
| NO952559L (no) | N-acyl-pyrrolidiner og medikamenter for behandling eller prevensjon av cholecystokinin- og gastrin-relaterte mangler | |
| GR3029737T3 (en) | Pyrimidine cyanoguanidines as k-channel blockers | |
| MXPA03008085A (es) | Derivados de acido fusidico poliaminados novedosos. | |
| ATE134632T1 (de) | Optisch aktives hydrochinin (amino-3-phenyl)-1- ethansulfonat, deren herstellung und verwendung | |
| DK0850225T3 (da) | Mellemprodukt til fremstilling af en farmaceutisk aktiv forbindelse |